Sign in

Rhenman & Partners Asset Management Ab

CIK:0001599882
Asset Manager
$973M AUM
90 holdings
Stockholm, Sweden
Founded:2008
15 employees
Latest filing:Jun 30, 2025

Rhenman & Partners Asset Management AB is an independent asset manager headquartered in Stockholm, Sweden, founded in 2008. The firm specializes exclusively in the healthcare sector and manages the portfolio for the Luxembourg-based Rhenman Healthcare Equity L/S fund. Their team consists of experienced financial professionals working closely with a Scientific Advisory Board of eminent medical experts. The firm serves both professional and retail investors in multiple European and Asian markets.

Investment Strategy

Rhenman & Partners Asset Management employs a highly specialized, sector-focused strategy investing only in healthcare companies, including pharmaceuticals, biotech, medical technology, and healthcare services. Their investment process integrates both scientific and financial analysis, leveraging close collaboration with a distinguished Scientific Advisory Board. This enables identification of emerging trends, breakthrough innovations, and opportunities for above-average returns by focusing strongly on a deep, research-driven understanding of healthcare markets and companies.

Latest 13F Filing Activity

Rhenman & Partners Asset Management Ab filed their most recent 13F report on Jun 30, 2025 disclosing 88 equity positions with a total 13F market value of $791M. The fund increased holdings in Danaher Corporation, Encompass Health Corp., Lilly Eli & Co. among other positions. Rhenman & Partners Asset Management Ab reduced exposure to United Health Group Inc., Bristol-myers Squibb Co., Molina Healthcare Inc. among others.

Top Buys
D
DHRDANAHER CORPORATION
+$15.4M
E
EHCENCOMPASS HEALTH CORP
+$12.9M
L
LLYLILLY ELI & CO
+$10.6M
C
CAHCARDINAL HEALTH INC
+$9.2M
N
NBIXNEUROCRINE BIOSCIENCES INC
+$8.8M
Top Sells
U
UNHUNITED HEALTH GROUP INC
-$31.1M
B
BMYBRISTOL-MYERS SQUIBB CO
-$19.8M
M
MOHMOLINA HEALTHCARE INC
-$15.9M
P
PRCTPROCEPT BIOROBOTICS CORP
-$15.2M
H
HUMHUMANA INC
-$12.4M

Top Holdings

L
LLYLILLY ELI & CO
+5.7%$45.1M
B
BSXBOSTON SCIENTIFIC CORP
+4.0%$31.8M
V
VRTXVERTEX PHARMACEUTICALS INC
+3.5%$27.4M
G
GKOSGLAUKOS CORP
+3.1%$24.3M
I
ISRGINTUITIVE SURGICAL INC
+3.0%$24.1M

Equity Positions (88)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
L
LLY
LILLY ELI & CO5.70%$45.1M57,870$567.90$779.53+$10.6M
B
BSX
BOSTON SCIENTIFIC CORP4.02%$31.8M296,000$42.53$107.41+$1.5M
V
VRTX
VERTEX PHARMACEUTICALS INC3.46%$27.4M61,455$321.21$445.20-$5.0M
G
GKOS
GLAUKOS CORP3.07%$24.3M235,000$100.05$103.29-$2.3M
I
ISRG
INTUITIVE SURGICAL INC3.05%$24.1M44,350$340.43$543.41-$1.4M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+34.0%
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
+13.8%
HOSPITAL & MEDICAL SERVICE PLANS
+9.4%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+7.6%
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
+5.8%